Indian Council of Medical Research Current Affairs, GK & News

ICMR Study: Mixed Covishield & Covaxin doses produce better immunity

Indian Council of Medical Research (ICMR) in a study found that, mixed Covid immunisation routine, with a dose of Covishield followed by one of Covaxin, is safe and produces a better immune response as compared to the uniform two doses of any of the two vaccines. Key Points Study titled ‘Serendipitous Covid-19 Vaccine-Mix in Uttar ..

Month: 

Category: 

Topics: 

Plasma Therapy for COVID-19 Treatment dropped

The Indian Council of Medical Research recently dropped the plasma therapy from COVID-19 treatment. The decision was taken as the procedure was found to be ineffective. Plasma Therapy In the therapy, the blood component called plasma from a COVID-19 recovered patient is injected into the COVID-19 infected patient. Plasma is a rich source of antibodies. ..

Month: 

Category: 

Topics: 

Infections after COVID Vaccination

The Indian Council of Medical Research recently reported that around two to four of the ten thousand vaccinated people tested positive for the disease. This is referred to as “Breakthrough Infection”. Key Findings of ICMR According to ICMR, around 9.3 million have received the first dose of COVAXIN. Of this, 4,208 have tested positive, which ..

Month: 

Category: 

Topics: 

GoI issues rules to manage Mental Illness amid COVID-19

The Ministry of Health and Family Welfare issued guidelines to manage mental illness during COVID-19 pandemic. The guidelines will help protect vulnerable patients and frontline health care workers. This is being done to reduce risk of COVID-19 exposure and protect patients against psychiatric disorders. Highlights The guidelines were issued based on the recommendation of Indian ..

Month: 

Category: 

Topics: 

COVAXIN to use Alhydroxiquim-II to boost Immune Response

The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has sought the approval of Drugs Controller General of India to begin phase III trials. The vaccine was jointly developed by Indian Council of Medical Research and Bharat-Biotech. ..

Month: 

Category: 

Topics: